跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Getabin-200 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Getabin-200
Approved
STANDARD
Getabin-200
Admac Lifesciences
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
4081287596f9ad80
Company
Admac Lifesciences
Type
Standard
Approval Details
Approval Id
4081287596f9ad80
Drug Approval Philippines Name
Getabin-200
Product Name
Getabin-200
Registration Number
DRP-8892
Brand Name
Getabin-200
Generic Name
Gemcitabine (as hydrochloride)
Dosage Form
Lyophilized Powder For Intravenous Injection
Dosage Strength
200mg
Manufacturer
Admac Lifesciences
Importer
Ambica International Corp.
Distributor
Ambica International Corp.
Issuance Date
25 July 2024
Expiry Date
29 May 2030
Pharmacologic Category
Antineoplastic Agent
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
4081287596f9ad80
Type
Standard
Back to Philippines FDA Approvals